Background information has now been posted for Thursday's session of the California stem cell agency's Standards Working Group in San Francisco(see item below). The documents involve a summary and response to public comments on proposed revisions to CIRM MES regulations along with reports dealing with clinical trials and reprogramming of adult stem cells.
Other subjects on the agenda include a report on CIRM guidelines for oocyte donation. That report is not available at the time of this writing.
No comments:
Post a Comment